SecBot SecBot
SECBOTREPLAY Home › Report › REGN

REGN · Regeneron Pharmaceuticals has filed definitive additional proxy…

REGENERON PHARMACEUTICALS, INC. · DEFA14A filed Apr 24, 2026 at 16:04 ET

At the news

NEUTRALIMPACT 3/10

DEFA14A filed Apr 24, 2026 at 16:04 ET

Regeneron Pharmaceuticals has filed definitive additional proxy soliciting materials (DEFA14A) with the SEC. This is a routine filing related to an upcoming shareholder vote, likely covering items such as director elections, executive compensation, or other corporate governance matters. The filing is from the registrant and is definitive, indicating that the final details for the vote have been provided to shareholders. There is no indication of activist involvement or contentious issues.

  • Company: Regeneron Pharmaceuticals, Inc. (REGN)
  • Form Type: DEFA14A (Definitive Additional Proxy Soliciting Materials)
  • Filing Status: Filed by the Registrant, Definitive
  • No activist involvement (SC 13D) or dissident campaign indicated

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access